Proposed key actions are to promote basic research, new leading technologies, and new interface research, including management of the enormous quantity of diverse data that the development of drugs delivers. Networking is considered essential and the creation of centralized databases and database networks at a European level is suggested. New European platforms for regulators and researchers are recommended to design the necessary changes to the drug development process in partnership and bring about improvements in capacity, efficacy, and speed (Table 3). The purpose is to exploit the enormous opportunities created by the genomic revolution and modern drug discovery for the generation of new medicines to the benefit of the European citizen .
Was this article helpful?